72 related articles for article (PubMed ID: 3791275)
1. Phase II trial of 10-deaza-aminopterin in advanced breast cancer.
Thongprasert S; Currie VE; Budman D
Cancer Treat Rep; 1987 Jan; 71(1):95-6. PubMed ID: 3791275
[No Abstract] [Full Text] [Related]
2. Phase I trial of 10-deaza-aminopterin in patients with advanced cancer.
Currie VE; Warrell RP; Arlin Z; Tan C; Sirotnak FM; Greene G; Young CW
Cancer Treat Rep; 1983 Feb; 67(2):149-54. PubMed ID: 6825121
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of 10-EDAM in the treatment of metastatic breast cancer.
Beinart GA; Gonzalez-Angulo AM; Broglio K; Frye D; Walters R; Holmes FA; Gunale S; Booser D; Rosenthal J; Dhingra K; Young JA; Hortobagyi GN
Cancer Chemother Pharmacol; 2007 Jun; 60(1):61-7. PubMed ID: 17009032
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of 10-deaza-aminopterin in patients with advanced colorectal cancer.
Cheng EW; Currie VE; Yagoda A
Am J Clin Oncol; 1983 Aug; 6(4):469-71. PubMed ID: 6869317
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of 10-deazaaminopterin for advanced hypernephroma.
Scher HI; Yagoda A; Ahmed T; Hollander P; Watson RC
Anticancer Res; 1984; 4(6):409-10. PubMed ID: 6517533
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of 10 deaza-aminopterin in patients with bladder cancer.
Ahmed T; Yagoda A; Scher HI; Sternberg C; Watson RC
Invest New Drugs; 1986; 4(2):171-4. PubMed ID: 3733377
[TBL] [Abstract][Full Text] [Related]
7. Phase I study of escalating doses of edatrexate in combination with paclitaxel in patients with metastatic breast cancer.
D'Andrea G; Fennelly D; Norton L; Baselga J; Gilewski T; Hudis C; Moynahan ME; Raptis G; Sklarin N; Surbone A; Theodoulou M; Templeton MA; Yao TJ; Seidman AD
Clin Cancer Res; 1999 Feb; 5(2):275-9. PubMed ID: 10037175
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of edatrexate in chemotherapy-naive patients with metastatic breast cancer.
Schornagel JH; van der Vegt S; Verweij J; de Graeff A; Dullemond-Westland A; van Deijk WA; ten Bokkel Huinink WW
Ann Oncol; 1992 Jul; 3(7):549-52. PubMed ID: 1498076
[TBL] [Abstract][Full Text] [Related]
9. Phase II evaluation of aclarubicin in advanced breast cancer: a Southeastern Cancer Study Group trial.
Gockerman JP; Raney M; Logan T
Cancer Treat Rep; 1985 Sep; 69(9):1029-30. PubMed ID: 3861247
[No Abstract] [Full Text] [Related]
10. Edatrexate (10-ethyl-deaza-aminopterin) (NSC #626715) with or without leucovorin rescue for malignant mesothelioma. Sequential phase II trials by the cancer and leukemia group B.
Kindler HL; Belani CP; Herndon JE; Vogelzang NJ; Suzuki Y; Green MR
Cancer; 1999 Nov; 86(10):1985-91. PubMed ID: 10570422
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of 4'-deoxydoxorubicin in patients with advanced breast cancer.
Leitner SP; Casper ES; Hakes TB; Kaufman RJ; Winn RJ; Scoppetuolo M; Raymond V; Geller NL; Young CW
Cancer Treat Rep; 1985 Nov; 69(11):1319-20. PubMed ID: 4092194
[TBL] [Abstract][Full Text] [Related]
12. 1,2,4-Triglycidylurazol in advanced breast cancer: a trial of the phase II study group of the Association of Medical Oncology, German Cancer Society.
Wander HE; Berdel WE; Bremer K; Peukert M; Queisser W
Cancer Treat Rep; 1987 Jan; 71(1):93-4. PubMed ID: 3791274
[No Abstract] [Full Text] [Related]
13. Phase II trial of aclarubicin in advanced breast cancer: a cancer and leukemia group B study.
Forastiere AA; Budman DR; Richards F; Aisner J; Weinberg V; Wood WC
Cancer Treat Rep; 1983 Dec; 67(12):1137-8. PubMed ID: 6580949
[No Abstract] [Full Text] [Related]
14. Phase II trial of prednimustine as first-line chemotherapy in patients with advanced breast cancer.
Rankin EM; Harvey C; Knight RK; Rubens RD
Cancer Treat Rep; 1987 Nov; 71(11):1107-8. PubMed ID: 3119205
[No Abstract] [Full Text] [Related]
15. Phase II trial of acivicin in advanced metastatic breast cancer.
Fleishman G; Yap HY; Murphy WK; Bodey G
Cancer Treat Rep; 1983 Sep; 67(9):843-4. PubMed ID: 6883364
[No Abstract] [Full Text] [Related]
16. Phase II evaluation of vindesine in patients with advanced breast cancer.
Currie VE; Camacho F; Wittes R; Young C
Cancer Treat Rep; 1980; 64(4-5):693-95. PubMed ID: 7427954
[No Abstract] [Full Text] [Related]
17. Phase II trial of spirogermanium for treatment of advanced breast cancer.
Falkson G; Falkson HC
Cancer Treat Rep; 1983 Feb; 67(2):189-90. PubMed ID: 6825129
[No Abstract] [Full Text] [Related]
18. Phase II study of spirogermanium in advanced breast cancer.
Kuebler JP; Tormey DC; Harper GR; Chang YC; Khandekar JD; Falkson G
Cancer Treat Rep; 1984 Dec; 68(12):1515-6. PubMed ID: 6509457
[No Abstract] [Full Text] [Related]
19. Aziridinylbenzoquinone (AZQ) in advanced breast cancer: a Cancer and Leukemia group B phase II trial.
Budman DR; Forastiere A; Perloff M; Perry M; Aisner J; Weinberg V; Wood W
Cancer Treat Rep; 1982 Oct; 66(10):1875-6. PubMed ID: 7127327
[No Abstract] [Full Text] [Related]
20. Phase II study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study.
Levin M; Pandya KJ; Khandekar JD; Horton J; Glick JH; Bennett JM; Muggia FM; Falkson G
Cancer Treat Rep; 1984 Dec; 68(12):1511-2. PubMed ID: 6509455
[No Abstract] [Full Text] [Related]
[Next] [New Search]
